5 of this year's biggest stock losers that are good bets in 2027

What happened

The article identifies Nike as the Dow’s worst-performing stock this year, down 34.8% through Nov. 4, while the Dow returned 12.4%. A hypothetical strategy buying each year’s prior-year Dow loser returned 11.1% annualized over the past decade, versus 6.9% for a Dow-tracking ETF.

Confirmed

Global impact / market context

The historical comparison suggests a possible rebound opportunity, but does not guarantee one. If investors buy Nike after its decline, their purchases could support its share price if the company’s performance improves; continued weakness could instead bring further losses and pressure investor returns.

Analyst inference

The article presents Nike’s decline as a contrarian opportunity: buying a stock that has fallen while many investors avoid it. It also reports that last year’s Dow laggard, UnitedHealth, has gained 26.4% this year, while suggesting investors wait until January because of year-end trading practices.

Analyst inference

What to watch

1. Watch whether Nike’s decline changes by year-end; the article reports a 34.8% fall through Nov. 4, against the Dow’s 12.4% total return. Confirmed
2. The article recommends considering a January entry instead of buying immediately, citing two Wall Street year-end practices; the excerpt does not identify both practices or their effects. Proposed
3. Compare Nike’s next-year performance with the historical strategy: buying the prior year’s Dow laggard. That strategy’s past returns do not establish what Nike will return. Analyst inference

Evidence

• Original source link unavailable